ND Pharma & Biotech
CORPORATE STRATEGY
Working with corporate partners.
ND PHARMA & BIOTECH focuses in developing pioneering and novel products, drugs, and molecules in specialist areas, from food to pharma and therapy where there is a distinct lack of existing solutions, with emphasis in personalized medicine and novel therapies in the field of Regenerative Medicine, Stem Cell Advancement and other like nutrition.
Since our foundation, our research strategy has been to work closely to different "first line" institutions and operational centers that conduct investigation for us, under guidance and supervision of our clinical & scientific director´s team. These institutional cooperation enables us to access innovative research and cutting edge discovery with substantial added value and immediate application to the developments under a relatively optimized costs. ND Pharma & Biotech maintains exclusive tights to all the intellectual property assets generated under such cooperation agreement and the research and development conducted.
Our market strategy, specially referred to pharmaceutical and therapeutic industry is to license our assets to leading international corporations and/or other industry operators (nutrition, food, feed, etc.) that are interested in further development and commercialization of some molecules and/or drugs.
We offer distinctive solutions to a number of unmet clinical conditions, diseases and pathologies.
Since our foundation, our research strategy has been to work closely to different "first line" institutions and operational centers that conduct investigation for us, under guidance and supervision of our clinical & scientific director´s team. These institutional cooperation enables us to access innovative research and cutting edge discovery with substantial added value and immediate application to the developments under a relatively optimized costs. ND Pharma & Biotech maintains exclusive tights to all the intellectual property assets generated under such cooperation agreement and the research and development conducted.
Our market strategy, specially referred to pharmaceutical and therapeutic industry is to license our assets to leading international corporations and/or other industry operators (nutrition, food, feed, etc.) that are interested in further development and commercialization of some molecules and/or drugs.
We offer distinctive solutions to a number of unmet clinical conditions, diseases and pathologies.
Business development and clients.
ND PHARMA & BIOTECH entered into some important and interesting corporate deals with major companies worldwide. So some of the "multi-billion dollar" corporations are now within our client´s list. Specifically within the food and nutrition industry we developed product innovation and license deals with the major producers of drinks, sodas, sport beverages and related industry sectors in the field, helping them to improve the quality, health and nutrition properties of their own products, both existing and other to appear. Other huge market corporations we work for include desert and ice-cream industry, infant nutrition labs and manufacturers, and large corporation of general foods.
ND PHARMA & BIOTECH also supply with active principles, transformation and refining of molecules and own developments to pharmaceutical industry including some of the "top ten" Pharma Corporations, with presence all around the world.
ND PHARMA & BIOTECH also supply with active principles, transformation and refining of molecules and own developments to pharmaceutical industry including some of the "top ten" Pharma Corporations, with presence all around the world.
Operations.
ND PHARMA & BIOTECH operations are conducted worldwide. Since our Company operates directly from our UK Headquarters, other related operational areas and for certain territories and countries may be conducted on case by case basis operations directly from different geographical areas or by delegates.
